deferoxamine has been researched along with Embolism, Pulmonary in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The resultant iron overload must be treated with chelation therapy using deferoxamine." | 7.69 | Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy. ( Berdon, WE; Hurlet-Jensen, A; Piomelli, S; Ruzal-Shapiro, C; Sheth, S, 1997) |
| " The resultant iron overload must be treated with chelation therapy using deferoxamine." | 3.69 | Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy. ( Berdon, WE; Hurlet-Jensen, A; Piomelli, S; Ruzal-Shapiro, C; Sheth, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheth, S | 1 |
| Ruzal-Shapiro, C | 1 |
| Hurlet-Jensen, A | 1 |
| Piomelli, S | 1 |
| Berdon, WE | 1 |
| Katoh, K | 1 |
| Takahashi, T | 1 |
| Yanagisawa, T | 1 |
| Mori, Y | 1 |
| Yamamoto, K | 1 |
| Senda, M | 1 |
| Fujita, T | 1 |
| Kumada, K | 1 |
| Fukui, K | 1 |
| Yonekura, Y | 1 |
| Yokoyama, A | 1 |
| Torizuka, K | 1 |
3 other studies available for deferoxamine and Embolism, Pulmonary
| Article | Year |
|---|---|
Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy.
Topics: Adolescent; Anemia, Sickle Cell; Catheterization, Central Venous; Chelation Therapy; Deferoxamine; F | 1997 |
[Abnormal plasminogen accompanying pulmonary embolism].
Topics: Adult; Deferoxamine; Fibrinogen; Humans; Male; Plasminogen; Pulmonary Embolism; Radionuclide Imaging | 1988 |
Positive imaging of venous thrombi and thromboemboli with Ga-67 DFO-DAS-fibrinogen.
Topics: Adult; Aged; Deferoxamine; Female; Fibrinogen; Gallium Radioisotopes; Humans; Male; Middle Aged; Pul | 1988 |